The Efficacy of Stellate Ganglion Block as Post-traumatic Stress Disorder (PTSD) Therapy: A Pilot Study
1 other identifier
interventional
12
1 country
1
Brief Summary
RATIONALE: A stellate ganglion nerve block may help relieve symptoms of post-traumatic stress disorder (PTSD). PURPOSE: This pilot clinical trial is studying the efficacy of a stellate ganglion nerve block in veterans to reduce the symptoms of PTSD in relatively long-standing (Vietnam era) induced or relatively recently induced PTSD (from deployment in Afghanistan or Iraq as part of Operations Enduring Freedom (OEF), Iraqi Freedom (OIF), and New Dawn (OND).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Feb 2012
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 12, 2012
CompletedFirst Posted
Study publicly available on registry
February 15, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedFebruary 15, 2012
February 1, 2012
1 year
February 12, 2012
February 14, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in CAPS score activity
Baseline and weeks 1, 4, 12 and 26
Secondary Outcomes (4)
Depression scale
Baseline and weeks 1, 4, 12 and 26
Anxiety scale
Baseline and weeks 1, 4, 12 and 26
Quality of life scale
Baseline and weeks 1, 4, 12 and 26
Biophysical responses
Baseline and weeks 1, 4, 12 and 26
Interventions
Local anesthesia applied to the stellate ganglion in the neck
Eligibility Criteria
You may qualify if:
- Include significant PTSD symptoms with severe hyper-arousal symptoms.
- Clinician Administered PTSD Scales (CAPS) score, with a total score ≥ 50 needed for enrollment.
- Hyper-arousal severity identified by a high score on the CAPS D scale and a ≥ 10 beat per minute increase in heart rate during the subject's verbal recollection of a standardized version of their traumatic exposure.
You may not qualify if:
- Include psychiatric and medical conditions that would make patients poor candidates for an outpatient procedure.
- Subjects must be able to be cooperative for the procedure and free of significant medical problems that would pose a constant threat to life.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Long Beach Healthcare system
Long Beach, California, 90803, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael T Alkire, MD
Long Beach VA Healthcare system
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2012
First Posted
February 15, 2012
Study Start
February 1, 2012
Primary Completion
February 1, 2013
Study Completion
February 1, 2013
Last Updated
February 15, 2012
Record last verified: 2012-02